GSK · GSK plc
AI read · Good for GSK
The AI's read
This gives GSK a new treatment option for some adults whose hepatitis B is already controlled. Trial results showed some patients stayed free of detectable virus after stopping treatment. Use is limited to eligible patients, and serious liver reactions and low platelet counts carry boxed warnings. The trial results and approval still favor GSK.